Scientific Board
An exclusive and well known scientific board is supporting RECARDIO’s strategy and decisions in scientific and clinical development:
Richard A. Schatz, MD
Advisory Board Chairman and Professor of Medicine, Interventional Cardiology, Research Director Scripps Clinic, Director of Gene and Stem Cell Research, La Jolla, USA
Bernd Jilma, MD
Associate Professor of Clinical Pharmacology and Internal Medicine, Vice Chair Department of Clinical Pharmacology, Medical University of Vienna, Austria
Jacek Kubica, MD Ph.D.
Professor of Medicine, Cardiologist, Head of Department of Cardiology and Internal Medicine, Collegium Medicum, Nicolaus Copernicus University, Bydgoszcz, Poland
Dirk von Lewinski, Assoz. Prof. Priv.-Doz. Dr.med.
Assoc. Prof. in Internal Medicine at the Medical University of Graz, Department of Cardiology; Head of Research unit Myocardial Energetics and Metabolism
Keith G. Oldroyd, MD
Interventional Cardiologist, West of Scotland Regional Heart & Lung Centre, Golden Jubilee National Hospital, Glasgow, UK
Thomas J. Povsic, MD Ph.D.
Associate Professor of Medicine, Head of Advanced Biomarkers Research, Duke Clinical Research Institute, Durham, USA
Joseph B. Selvanayagam, MD
Professor of Cardiology, Flinders University of South Australia, Adelaide, Australia
Corporate Board
Dr. Roman Schenk
Dr. Roman Schenk is founder, former CEO and since 2016 Executive Chairman of RECARDIO Inc.
Dr. Roman Schenk is founder, former CEO and since 2016 Executive Chairman of RECARDIO Inc.
Prior to founding RECARDIO he was founder and CEO of various start-up companies in life sciences. He is board member of various health care companies and international organizations. Before starting his entrepreunial career he held various european management positions in research, marketing and business development in the pharmaceutical industry.